Aisling CapitalInvestor Details

Get alertedif Aisling Capital makes an investment
Aisling Capital
United States
New York
New York City
Company description

Aisling Capital is a late-stage life sciences investment partnership that leverages nearly 20 years of capital markets and clinical experience to invest in the development of breakthrough therapeutics that improve and save lives.


Funding history

DateDeal sizeInvestors
November 2nd, 2017$280,000,000-
Want to know when Aisling Capital invests in a new company?
Nuvation Bio Inc (2019: $275,000,000 raised)
Ajax Health (2019: $15,000,000 raised)
Poseida Therapeutics Inc (2019: $142,000,000 raised)
Bridgebio Llc (2019: $299,200,000 raised)
Earlens Corporation Inc (2018: $87,000,000 raised)
Nference (2018: $11,000,000 raised)
Eidos Therapeutics (2018: $64,000,000 raised)
Arcus Biosciences (2017: $107,000,000 raised)
Menlo Therapeutics (2017: $50,000,000 raised)
Earlens Corporation Inc (2017: $45,000,000 raised)
Promentis Pharmaceuticals Inc (2017: $26,000,000 raised)
Biohaven Pharmaceutical Holding Company Ltd (2016: $80,000,000 raised)
Verona Pharma Plc (2016: $65,600,000 raised)
F2g Ltd (2016: $60,000,000 raised)
Zavante Therapeutics Inc (2016: $35,000,000 raised)
Spirox Inc (2016: $45,000,000 raised)
Syros Pharmaceuticals (2016: $40,000,000 raised)
Allergen Research Corp (2015: $80,000,000 raised)
Syros Pharmaceuticals (2014: $53,000,000 raised)
Dermira Inc (2014: $51,000,000 raised)
Cidara Therapeutics (2014: $32,000,000 raised)
Powervision Inc (2014: $30,000,000 raised)
Loxo Oncology Inc (2014: $24,000,000 raised)
Viewray Inc (2014: $30,000,000 raised)
Versartis Inc (2013: $20,000,000 raised)
Loxo Oncology Inc (2013: $33,000,000 raised)
Lensar Inc (2013: $87,000,000 raised)
Esperion Therapeutics (2013: $33,000,000 raised)
T2 Biosystems Inc (2013: $40,000,000 raised)
Versartis Inc (2013: $25,000,000 raised)
Ambit Biosciences Corp (2012: $25,000,000 raised)
Axiomed Spine (2012: $5,000,000 raised)
Cytos Biotechnology Ag (2012: $32,600,000 raised)
Lensar Inc (2012: $24,000,000 raised)
Aragon Pharmaceuticals Inc (2012: $42,000,000 raised)
New Enterprise Associates
OrbiMed Advisors
Longitude Capital
Polaris Partners
Ra Capital Management
Redmile Group
Rock Springs Capital
Advent Life Sciences Fund
Aperture Venture Partners Llc
Boxer Capital Llc
Ecor1 Capital
Fidelity Biosciences
Flagship Ventures
Foresite Capital
Healthquest Capital
Index Ventures
Kearny Venture Partners
Lightstone Ventures Lp
New Leaf Venture Partners Llc
Novo A/S
The Column Group
Vivo Capital
5AM Ventures
ARCH Venture Partners
Adage Capital
Advent Life Sciences Llp
Alexandria Venture Investments
Alta Partners
Altitude Life Science Ventures
Amunix Operating Inc
Amzak Health Investors
Apple Tree Partners
Apposite Healthcare
Arboretum Ventures And Asset Management
Arch Healthcare
Arcus Ventures
Arix Bioscience
Baltisches Haus Ltd
Bay City Capital Llc
Black Pearl Gmbh
Boxer Capital Of The Tavistock Group
Brace Pharma Capital
Bridgebio Pharma
Bvf Partners
Camros Capital
Canaan Partners
Casdin Capital
Connecticut Innovations
Cormorant Asset Management
Cormorant Capital
Correlation Venture Partners
Cowealth Medical Holding Co Ltd
Crg Partners
Decheng Capital
Deerfield Management Company
Domain Associates
Edmond de Rothschild Investment Partners
Exor Seeds
F-prime Capital Partners
Far East Ventures
Fidelity Management
Fidelity Management & Research Company
Florida Growth
Florida Growth Fund
Florida Opportunity Funds
Flybridge Capital Partners Lp
Forward Ventures
Frazier Healthcare
Frazier Healthcare Partners
Gdn Holdings
Golden Angel Network
Goldman Sachs
Gv (google Ventures)
Hargreave Hale
Hercules Capital
InterWest Partners
Invus Opportunities
Ivo Capital
Kck Medical Technologies Group
Knoll Capital Management
Leerink Partners Llc
Litmore Capital
Malin Corp
Matrix Capital Management
Matrix Partners
Medimmune Ventures Inc
Medtronic Corp
Merifin Capital
Ms Pace Lp
New Enterprise Associates (nea)
Novartis Venture Fund
Novo Holdings A/s
Omega Funds
Osage University Partners
Palo Alto Investors
Partners Healthcare
Pavilion Capital
Pdl Biopharma
Pentwater Capital Management Lp
Perceptive Advisors Llc
Physic Ventures
Polar Capital
Radius Ventures
Rapha Capital Management
Relativity Health Fund
Research Company
Rk Mellon
Roche Ventures
Sabby Capital
Sectoral Asset Management
Sequoia Capital
Siemens Venture Capital
Sightline Healthcare Opportunity
Sightline Partners
Sofinnova Ventures
Sunstone Capital
Surveyor Capital
Taiho Ventures
The Baupost Group
Topspin Fund
Vertex Global Healthcare
Vertex Healthcare
Viking Global Investors
Viking Venture
Wellington Management
Windham Life Sciences Partners
Windham Venture Partners
Ws Investments
Wuxi Pharmatech Corporate Venture Fund
Wuxi Ventures Funds
This list displays investors that took part in the same funding round as Aisling Capital since March 2012. They are displayed in decreasing order of coinvesting frequency.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!